Pre-emptive immune therapy to prevent relapse of myeloid malignancies

Project: Research

Project Details

StatusFinished
Effective start/end date1/08/201331/12/2017

Collaborative partners

Funding

  • Blood Cancer UK: £1,092,923.00
  • Blood Cancer UK: £77,609.00
  • Blood Cancer UK: £37,888.00